Table of Contents Table of Contents
Previous Page  1310 / 1851 Next Page
Information
Show Menu
Previous Page 1310 / 1851 Next Page
Page Background

Time-to-events endpoints (38)

As you can see there are many different time to event endpoints, with very subtle

differences and different papers may even use different names for the same outcome:

Results from systematic review of RCTs of systemic

therapy for EBC

DFS RFS EFS TTR Total

LR + DR + CLB + NBSP + Death

7

0

2

0

9

LR + DR + CLB + DCIS + Death

1

0

0

0

1

LR + DR + CLB + DCIS + BC Death

0

0

0

1

1

LR + DR + CLB + Death

3

0

0

0

3

LR + DR + CLB + NBSP

1

0

0

0

1

LR + DR + CLB

2

3

0

1

6

LR + DR + Death

6

1

1

1

9

LR + DR

3

3

0

1

7

LR + DR + BC Death

0

1

0

0

1

Table: Lucy S Kilburn

Clinical Trials & Statistics Unit (ICR-CTSU),

The Institute of Cancer Research, London, UK

LR = local recurrence, DR =distant recurrence, CLB= contralateral breast,

NBSP =National Breast Screening Programme